76.82 USD
↘ 0.01 (0.01%)LIVE (AS OF 09:46 AM EDT)
Forte Biosciences, Inc. Common Stock
FBRXNASDAQ • USD
Market: OPEN
Forte Biosciences, Inc. Common Stock (FBRX) trades at $76.82 per share. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation front, FBRX trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Aug 6, 2026.
Open?$76.82
High?$76.83
Low?$76.81
Prev. Close?$76.83
Volume?20.8K
Avg. Volume?1.9M
VWAP?$76.81
Rel. Volume?0.01x
Bid / Ask
Bid?$66.02 × 100
Ask?$87.59 × 100
Spread?$21.57
Midpoint?$76.81
Valuation & Ratios
Market Cap?1.6B
Shares Out?20.5M
Float?17.2M
Float %?84.2%
P/E Ratio?N/A
P/B Ratio?37.39
EPS?-$3.70
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Themes
Employees
22
Market Cap
1.6B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-06-16
Address
3060 PEGASUS PARK DRIVE
DALLAS, TX 75247
Phone: (310) 618-6994
DALLAS, TX 75247
Phone: (310) 618-6994
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?61
Piotroski F-Score?0/9Weak
Altman Z-Score?29.45Safe
Confidence?45%Low
Short InterestHigh
Short % of Float?11.95%High
Short Interest?2.1M
Days to Cover?1.7
Free Float17.2M
Avg Daily Volume1.2M
Settlement Date2026-07-15
Financial Health
Current Ratio?2.75Strong
Quick Ratio?2.75Strong
Cash Ratio?2.46Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?37.39HIGH▾
Peers100
S&P3
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-19.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-180.2%WEAK▾
S&P3
ROA?-112.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-59390000
Enterprise Value?$1.5B
Fundamentals ratios updated end of day